May 2026, Volume 4, Issue 5

Author

Minu Bajpai and Abhijat C. Sheth

Abstract

India's engagement with stem cell science has traversed a remarkable arc-from early exploratory research to the threshold of clinically meaningful, technology-driven regenerative medicine. Yet, the next phase of evolution will not be defined merely by incremental scientific advances, but by the country's ability to translate biological promise into scalable, evidence-based, and equitable healthcare solutions. This transition is being shaped by converging technological trajectories-gene editing, tissue engineering, artificial intelligence, and advanced manufacturing-while simultaneously demanding the creation of robust foundational infrastructure. Among these, national biobank repositories stand out as a strategic cornerstone, enabling precision, reproducibility, and acceleration of translational pipelines.